nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpropamide—CYP2C19—Sorafenib—thyroid cancer	0.122	0.32	CbGbCtD
Chlorpropamide—CYP2C9—Sorafenib—thyroid cancer	0.102	0.266	CbGbCtD
Chlorpropamide—ABCB1—Sorafenib—thyroid cancer	0.0985	0.258	CbGbCtD
Chlorpropamide—ABCB1—Doxorubicin—thyroid cancer	0.0598	0.156	CbGbCtD
Chlorpropamide—PTGS1—Eicosanoid Synthesis—PTGES2—thyroid cancer	0.0257	0.107	CbGpPWpGaD
Chlorpropamide—Glipizide—PPARG—thyroid cancer	0.0196	1	CrCbGaD
Chlorpropamide—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGD—thyroid cancer	0.0193	0.0801	CbGpPWpGaD
Chlorpropamide—Hypoglycaemia—Vandetanib—thyroid cancer	0.016	0.0447	CcSEcCtD
Chlorpropamide—Hyponatraemia—Vandetanib—thyroid cancer	0.0156	0.0438	CcSEcCtD
Chlorpropamide—Drug interaction—Sorafenib—thyroid cancer	0.0156	0.0437	CcSEcCtD
Chlorpropamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.0137	0.0569	CbGpPWpGaD
Chlorpropamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.0133	0.0551	CbGpPWpGaD
Chlorpropamide—Photosensitivity reaction—Vandetanib—thyroid cancer	0.0123	0.0344	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.0111	0.0312	CcSEcCtD
Chlorpropamide—Hyponatraemia—Sorafenib—thyroid cancer	0.0105	0.0295	CcSEcCtD
Chlorpropamide—PTGS1—Prostaglandin Synthesis and Regulation—HPGD—thyroid cancer	0.0105	0.0435	CbGpPWpGaD
Chlorpropamide—Erythema multiforme—Vandetanib—thyroid cancer	0.0102	0.0285	CcSEcCtD
Chlorpropamide—Eruption—Epirubicin—thyroid cancer	0.0087	0.0243	CcSEcCtD
Chlorpropamide—Eruption—Doxorubicin—thyroid cancer	0.00805	0.0225	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Vandetanib—thyroid cancer	0.0075	0.021	CcSEcCtD
Chlorpropamide—PTGS1—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00697	0.0289	CbGpPWpGaD
Chlorpropamide—Erythema multiforme—Sorafenib—thyroid cancer	0.00687	0.0192	CcSEcCtD
Chlorpropamide—Dyspepsia—Vandetanib—thyroid cancer	0.00674	0.0189	CcSEcCtD
Chlorpropamide—Decreased appetite—Vandetanib—thyroid cancer	0.00666	0.0186	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00661	0.0185	CcSEcCtD
Chlorpropamide—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00609	0.017	CcSEcCtD
Chlorpropamide—Leukopenia—Sorafenib—thyroid cancer	0.00566	0.0159	CcSEcCtD
Chlorpropamide—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00563	0.0158	CcSEcCtD
Chlorpropamide—ABCC8—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.00556	0.023	CbGpPWpGaD
Chlorpropamide—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—thyroid cancer	0.00547	0.0227	CbGpPWpGaD
Chlorpropamide—Pruritus—Vandetanib—thyroid cancer	0.00542	0.0152	CcSEcCtD
Chlorpropamide—KCNJ11—Regulation of insulin secretion—PRKAR1A—thyroid cancer	0.00539	0.0223	CbGpPWpGaD
Chlorpropamide—Diarrhoea—Vandetanib—thyroid cancer	0.00524	0.0147	CcSEcCtD
Chlorpropamide—Fluid retention—Epirubicin—thyroid cancer	0.00508	0.0142	CcSEcCtD
Chlorpropamide—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—thyroid cancer	0.00507	0.021	CbGpPWpGaD
Chlorpropamide—Dizziness—Vandetanib—thyroid cancer	0.00506	0.0142	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Sorafenib—thyroid cancer	0.00506	0.0142	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Epirubicin—thyroid cancer	0.00502	0.0141	CcSEcCtD
Chlorpropamide—Anorexia—Sorafenib—thyroid cancer	0.00492	0.0138	CcSEcCtD
Chlorpropamide—Vomiting—Vandetanib—thyroid cancer	0.00487	0.0136	CcSEcCtD
Chlorpropamide—Rash—Vandetanib—thyroid cancer	0.00483	0.0135	CcSEcCtD
Chlorpropamide—Headache—Vandetanib—thyroid cancer	0.0048	0.0134	CcSEcCtD
Chlorpropamide—Fluid retention—Doxorubicin—thyroid cancer	0.0047	0.0132	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00465	0.013	CcSEcCtD
Chlorpropamide—Nausea—Vandetanib—thyroid cancer	0.00455	0.0127	CcSEcCtD
Chlorpropamide—Dyspepsia—Sorafenib—thyroid cancer	0.00455	0.0127	CcSEcCtD
Chlorpropamide—Decreased appetite—Sorafenib—thyroid cancer	0.00449	0.0126	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00446	0.0125	CcSEcCtD
Chlorpropamide—ABCC8—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.00437	0.0181	CbGpPWpGaD
Chlorpropamide—KCNJ11—Integration of energy metabolism—PRKAR1A—thyroid cancer	0.00424	0.0176	CbGpPWpGaD
Chlorpropamide—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00412	0.0115	CcSEcCtD
Chlorpropamide—Urticaria—Sorafenib—thyroid cancer	0.0041	0.0115	CcSEcCtD
Chlorpropamide—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00402	0.0167	CbGpPWpGaD
Chlorpropamide—Hypoglycaemia—Epirubicin—thyroid cancer	0.00398	0.0111	CcSEcCtD
Chlorpropamide—Hyponatraemia—Epirubicin—thyroid cancer	0.0039	0.0109	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00381	0.0107	CcSEcCtD
Chlorpropamide—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00368	0.0103	CcSEcCtD
Chlorpropamide—CYP2C9—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00367	0.0152	CbGpPWpGaD
Chlorpropamide—Pruritus—Sorafenib—thyroid cancer	0.00365	0.0102	CcSEcCtD
Chlorpropamide—Hyponatraemia—Doxorubicin—thyroid cancer	0.00361	0.0101	CcSEcCtD
Chlorpropamide—Diarrhoea—Sorafenib—thyroid cancer	0.00353	0.00989	CcSEcCtD
Chlorpropamide—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—thyroid cancer	0.00346	0.0144	CbGpPWpGaD
Chlorpropamide—Dizziness—Sorafenib—thyroid cancer	0.00342	0.00956	CcSEcCtD
Chlorpropamide—Eosinophilia—Epirubicin—thyroid cancer	0.00332	0.0093	CcSEcCtD
Chlorpropamide—Vomiting—Sorafenib—thyroid cancer	0.00328	0.00919	CcSEcCtD
Chlorpropamide—Rash—Sorafenib—thyroid cancer	0.00326	0.00912	CcSEcCtD
Chlorpropamide—Headache—Sorafenib—thyroid cancer	0.00324	0.00906	CcSEcCtD
Chlorpropamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.00322	0.0133	CbGpPWpGaD
Chlorpropamide—Pancytopenia—Epirubicin—thyroid cancer	0.00319	0.00892	CcSEcCtD
Chlorpropamide—Eosinophilia—Doxorubicin—thyroid cancer	0.00307	0.00861	CcSEcCtD
Chlorpropamide—Nausea—Sorafenib—thyroid cancer	0.00307	0.00859	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00306	0.00858	CcSEcCtD
Chlorpropamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.00299	0.0124	CbGpPWpGaD
Chlorpropamide—Pancytopenia—Doxorubicin—thyroid cancer	0.00295	0.00826	CcSEcCtD
Chlorpropamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.00291	0.0121	CbGpPWpGaD
Chlorpropamide—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00283	0.00794	CcSEcCtD
Chlorpropamide—Agranulocytosis—Epirubicin—thyroid cancer	0.00279	0.00782	CcSEcCtD
Chlorpropamide—PTGS1—Overview of nanoparticle effects—PTGS2—thyroid cancer	0.00271	0.0113	CbGpPWpGaD
Chlorpropamide—Agranulocytosis—Doxorubicin—thyroid cancer	0.00258	0.00723	CcSEcCtD
Chlorpropamide—Erythema multiforme—Epirubicin—thyroid cancer	0.00254	0.00711	CcSEcCtD
Chlorpropamide—Erythema multiforme—Doxorubicin—thyroid cancer	0.00235	0.00658	CcSEcCtD
Chlorpropamide—PTGS1—Eicosanoid Synthesis—PTGS2—thyroid cancer	0.00225	0.00933	CbGpPWpGaD
Chlorpropamide—Leukopenia—Epirubicin—thyroid cancer	0.00209	0.00586	CcSEcCtD
Chlorpropamide—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00208	0.00861	CbGpPWpGaD
Chlorpropamide—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00203	0.0084	CbGpPWpGaD
Chlorpropamide—Leukopenia—Doxorubicin—thyroid cancer	0.00194	0.00542	CcSEcCtD
Chlorpropamide—SLC15A2—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00192	0.00797	CbGpPWpGaD
Chlorpropamide—SLC15A2—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00192	0.00797	CbGpPWpGaD
Chlorpropamide—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00189	0.00785	CbGpPWpGaD
Chlorpropamide—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.00188	0.00781	CbGpPWpGaD
Chlorpropamide—Thrombocytopenia—Epirubicin—thyroid cancer	0.00187	0.00523	CcSEcCtD
Chlorpropamide—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.00183	0.00759	CbGpPWpGaD
Chlorpropamide—Anorexia—Epirubicin—thyroid cancer	0.00182	0.00509	CcSEcCtD
Chlorpropamide—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.00181	0.00748	CbGpPWpGaD
Chlorpropamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.0018	0.00745	CbGpPWpGaD
Chlorpropamide—SLC15A1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00178	0.00739	CbGpPWpGaD
Chlorpropamide—SLC15A1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00178	0.00739	CbGpPWpGaD
Chlorpropamide—PTGS1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00177	0.00732	CbGpPWpGaD
Chlorpropamide—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00173	0.00484	CcSEcCtD
Chlorpropamide—Anorexia—Doxorubicin—thyroid cancer	0.00168	0.00471	CcSEcCtD
Chlorpropamide—Dyspepsia—Epirubicin—thyroid cancer	0.00168	0.0047	CcSEcCtD
Chlorpropamide—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	0.00167	0.00692	CbGpPWpGaD
Chlorpropamide—Decreased appetite—Epirubicin—thyroid cancer	0.00166	0.00464	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00165	0.00461	CcSEcCtD
Chlorpropamide—Dyspepsia—Doxorubicin—thyroid cancer	0.00155	0.00435	CcSEcCtD
Chlorpropamide—Decreased appetite—Doxorubicin—thyroid cancer	0.00154	0.0043	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00152	0.00427	CcSEcCtD
Chlorpropamide—Urticaria—Epirubicin—thyroid cancer	0.00152	0.00424	CcSEcCtD
Chlorpropamide—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00144	0.00596	CbGpPWpGaD
Chlorpropamide—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.00142	0.00587	CbGpPWpGaD
Chlorpropamide—Urticaria—Doxorubicin—thyroid cancer	0.0014	0.00393	CcSEcCtD
Chlorpropamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.00139	0.00575	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—MINPP1—thyroid cancer	0.00137	0.00569	CbGpPWpGaD
Chlorpropamide—Pruritus—Epirubicin—thyroid cancer	0.00135	0.00378	CcSEcCtD
Chlorpropamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.00135	0.00558	CbGpPWpGaD
Chlorpropamide—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00133	0.00553	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—MINPP1—thyroid cancer	0.00133	0.00552	CbGpPWpGaD
Chlorpropamide—SLC22A6—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00132	0.00549	CbGpPWpGaD
Chlorpropamide—SLC22A6—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00132	0.00549	CbGpPWpGaD
Chlorpropamide—Diarrhoea—Epirubicin—thyroid cancer	0.00131	0.00366	CcSEcCtD
Chlorpropamide—Dizziness—Epirubicin—thyroid cancer	0.00126	0.00353	CcSEcCtD
Chlorpropamide—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00126	0.00521	CbGpPWpGaD
Chlorpropamide—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.00125	0.00519	CbGpPWpGaD
Chlorpropamide—Pruritus—Doxorubicin—thyroid cancer	0.00125	0.0035	CcSEcCtD
Chlorpropamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.00122	0.00505	CbGpPWpGaD
Chlorpropamide—Vomiting—Epirubicin—thyroid cancer	0.00121	0.0034	CcSEcCtD
Chlorpropamide—Diarrhoea—Doxorubicin—thyroid cancer	0.00121	0.00338	CcSEcCtD
Chlorpropamide—Rash—Epirubicin—thyroid cancer	0.0012	0.00337	CcSEcCtD
Chlorpropamide—Headache—Epirubicin—thyroid cancer	0.0012	0.00335	CcSEcCtD
Chlorpropamide—Dizziness—Doxorubicin—thyroid cancer	0.00117	0.00327	CcSEcCtD
Chlorpropamide—ABCC8—Metabolism—NDUFA13—thyroid cancer	0.00117	0.00484	CbGpPWpGaD
Chlorpropamide—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00114	0.00475	CbGpPWpGaD
Chlorpropamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.00114	0.00472	CbGpPWpGaD
Chlorpropamide—Nausea—Epirubicin—thyroid cancer	0.00113	0.00317	CcSEcCtD
Chlorpropamide—KCNJ11—Metabolism—NDUFA13—thyroid cancer	0.00113	0.00469	CbGpPWpGaD
Chlorpropamide—Vomiting—Doxorubicin—thyroid cancer	0.00112	0.00314	CcSEcCtD
Chlorpropamide—Rash—Doxorubicin—thyroid cancer	0.00111	0.00312	CcSEcCtD
Chlorpropamide—Headache—Doxorubicin—thyroid cancer	0.00111	0.0031	CcSEcCtD
Chlorpropamide—ABCC8—Metabolism—CHST14—thyroid cancer	0.0011	0.00455	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—CP—thyroid cancer	0.00108	0.0045	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00108	0.0045	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00107	0.00442	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—CHST14—thyroid cancer	0.00106	0.00441	CbGpPWpGaD
Chlorpropamide—Nausea—Doxorubicin—thyroid cancer	0.00105	0.00294	CcSEcCtD
Chlorpropamide—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00102	0.00422	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000997	0.00413	CbGpPWpGaD
Chlorpropamide—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000991	0.00411	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000976	0.00405	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000976	0.00405	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00096	0.00398	CbGpPWpGaD
Chlorpropamide—PTGS1—Biological oxidations—RXRA—thyroid cancer	0.000938	0.00389	CbGpPWpGaD
Chlorpropamide—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000928	0.00385	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000906	0.00376	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000906	0.00376	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000891	0.0037	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—HPGD—thyroid cancer	0.000884	0.00367	CbGpPWpGaD
Chlorpropamide—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000882	0.00366	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—HPGD—thyroid cancer	0.000857	0.00356	CbGpPWpGaD
Chlorpropamide—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000843	0.0035	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000812	0.00337	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000796	0.0033	CbGpPWpGaD
Chlorpropamide—ABCC8—Neuronal System—BRAF—thyroid cancer	0.00078	0.00323	CbGpPWpGaD
Chlorpropamide—KCNJ11—Neuronal System—BRAF—thyroid cancer	0.000756	0.00314	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000731	0.00303	CbGpPWpGaD
Chlorpropamide—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000721	0.00299	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—MINPP1—thyroid cancer	0.000689	0.00286	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000682	0.00283	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000678	0.00281	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000673	0.00279	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	0.000673	0.00279	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000662	0.00274	CbGpPWpGaD
Chlorpropamide—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000658	0.00273	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000614	0.00255	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—NDUFA13—thyroid cancer	0.000586	0.00243	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000575	0.00238	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.00057	0.00236	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—CHST14—thyroid cancer	0.000551	0.00228	CbGpPWpGaD
Chlorpropamide—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.000541	0.00224	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000524	0.00217	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—TPR—thyroid cancer	0.000508	0.00211	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000503	0.00209	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—PRKAR1A—thyroid cancer	0.0005	0.00207	CbGpPWpGaD
Chlorpropamide—CYP2C9—Biological oxidations—RXRA—thyroid cancer	0.000493	0.00204	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—TPR—thyroid cancer	0.000492	0.00204	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000485	0.00201	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—PRKAR1A—thyroid cancer	0.000484	0.00201	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—HPGD—thyroid cancer	0.000444	0.00184	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000423	0.00175	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—MINPP1—thyroid cancer	0.000397	0.00165	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—MINPP1—thyroid cancer	0.000388	0.00161	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—SLC5A5—thyroid cancer	0.00038	0.00158	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—SLC5A5—thyroid cancer	0.000369	0.00153	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—MINPP1—thyroid cancer	0.000362	0.0015	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.00036	0.00149	CbGpPWpGaD
Chlorpropamide—ABCC8—Neuronal System—HRAS—thyroid cancer	0.000359	0.00149	CbGpPWpGaD
Chlorpropamide—KCNJ11—Neuronal System—HRAS—thyroid cancer	0.000348	0.00144	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—NDUFA13—thyroid cancer	0.000338	0.0014	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—NDUFA13—thyroid cancer	0.00033	0.00137	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—RXRA—thyroid cancer	0.000319	0.00132	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—CHST14—thyroid cancer	0.000318	0.00132	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—CHST14—thyroid cancer	0.00031	0.00128	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—RXRA—thyroid cancer	0.00031	0.00128	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—NDUFA13—thyroid cancer	0.000308	0.00128	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000306	0.00127	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000306	0.00127	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000301	0.00125	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—CHST14—thyroid cancer	0.00029	0.0012	CbGpPWpGaD
Chlorpropamide—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.000283	0.00118	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—HPGD—thyroid cancer	0.000256	0.00106	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—TPR—thyroid cancer	0.000255	0.00106	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—PRKAR1A—thyroid cancer	0.000251	0.00104	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—HPGD—thyroid cancer	0.00025	0.00104	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000241	0.000999	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—HPGD—thyroid cancer	0.000233	0.000968	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000229	0.000951	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000227	0.000943	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000218	0.000903	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.00021	0.000871	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000208	0.000861	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—PPARG—thyroid cancer	0.000202	0.000836	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—PPARG—thyroid cancer	0.000196	0.000811	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000193	0.000799	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—SLC5A5—thyroid cancer	0.000191	0.000791	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000189	0.000785	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000179	0.000742	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000161	0.000669	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—RXRA—thyroid cancer	0.00016	0.000665	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—PTGS2—thyroid cancer	0.000159	0.000658	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000156	0.000647	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—PTGS2—thyroid cancer	0.000154	0.000638	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—TPR—thyroid cancer	0.000147	0.000609	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	0.000145	0.0006	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—TPR—thyroid cancer	0.000143	0.000595	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000143	0.000595	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—PRKAR1A—thyroid cancer	0.000141	0.000585	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—PTEN—thyroid cancer	0.000138	0.000574	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—PTEN—thyroid cancer	0.000134	0.000556	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—TPR—thyroid cancer	0.000134	0.000556	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	0.000132	0.000547	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000131	0.000543	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000121	0.000502	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.00012	0.000496	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—SLC5A5—thyroid cancer	0.00011	0.000456	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—SLC5A5—thyroid cancer	0.000107	0.000445	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000103	0.000428	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—PPARG—thyroid cancer	0.000101	0.00042	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—SLC5A5—thyroid cancer	0.0001	0.000416	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.4e-05	0.00039	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—RXRA—thyroid cancer	9.25e-05	0.000383	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—RXRA—thyroid cancer	9.02e-05	0.000374	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.99e-05	0.000373	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—RXRA—thyroid cancer	8.43e-05	0.00035	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.2e-05	0.00034	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—AKT1—thyroid cancer	7.97e-05	0.000331	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—PTGS2—thyroid cancer	7.96e-05	0.00033	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—AKT1—thyroid cancer	7.73e-05	0.000321	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—PTEN—thyroid cancer	6.95e-05	0.000288	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—PPARG—thyroid cancer	5.84e-05	0.000242	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—PPARG—thyroid cancer	5.7e-05	0.000236	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—PPARG—thyroid cancer	5.32e-05	0.000221	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—PTGS2—thyroid cancer	4.59e-05	0.00019	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—PTGS2—thyroid cancer	4.48e-05	0.000186	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—PTGS2—thyroid cancer	4.19e-05	0.000174	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—PTEN—thyroid cancer	4e-05	0.000166	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—AKT1—thyroid cancer	4e-05	0.000166	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—PTEN—thyroid cancer	3.91e-05	0.000162	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—PTEN—thyroid cancer	3.65e-05	0.000151	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—AKT1—thyroid cancer	2.31e-05	9.57e-05	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—AKT1—thyroid cancer	2.25e-05	9.34e-05	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—AKT1—thyroid cancer	2.1e-05	8.73e-05	CbGpPWpGaD
